# PGNY — Progyny · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** PGNY  
**Sources:** 26  
**Published:** 2026-09-26  
**Canonical:** https://app.k3vl4r.com/research/deep-research-pgny-progyny-catalysts-narrative-risks-4818

---

## Snapshot

Progyny, Inc. (Nasdaq: PGNY) is a New York–based employer-sponsored fertility, family-building, and women's-health benefits manager that completed its Nasdaq IPO in 2019 [[1]](https://www.marketscreener.com/news/progyny-inc-reports-earnings-results-for-the-third-quarter-and-nine-months-ended-september-30-202-ce785fdfd08cf325)[[21]](https://en.wikipedia.org/wiki/Progyny). It is classified within the digital-health space in our coverage universe [[1]](https://www.marketscreener.com/news/progyny-inc-reports-earnings-results-for-the-third-quarter-and-nine-months-ended-september-30-202-ce785fdfd08cf325). As of the Nov 13, 2026 close, the stock last traded at $36.18, down 1.09% on the day [[8]](https://finance.yahoo.com/quote/PGNY/news/), and has been cited near a $2.6B market capitalization [[13]](https://news.alphastreet.com/progyny-surges-13-5-after-wells-fargo-maintains-overweight/). The stock's sensitivity to news flow is consistent with the research library's observation that financial-news sentiment and price discovery interact closely in equity moves [LIB-1][LIB-2].

## Recent catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-pgny-progyny-catalysts-narrative-risks-4818 (free to sign up)._
